Stay updated on Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-10-31T13:14:10.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.
    Difference
    0.3%
    Check dated 2026-10-24T13:50:34.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-17T13:54:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-10T15:39:12.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    A new record version dated 2026-09-28 updates the trial’s eligibility information and study status. The prior version is dated 2026-09-03, replacing the earlier 2026-07-06 date.
    Difference
    0.2%
    Check dated 2026-10-03T15:38:34.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The revision label on the page was updated from Revision: v3.6.6 to Revision: v3.7.0, representing a new version of the page's history component.
    Difference
    0.0%
    Check dated 2026-09-19T19:08:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in 1L NSCLC Maintenance Clinical Trial page.